The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Dialysis

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Dialysis

  • Parathyroid function was assessed by inducing hypo- and hypercalcemia with low calcium (1.0 mEq/liter) and high calcium (4.0 mEq/liter) dialyses before and after ten weeks of intravenous calcitriol therapy [1].
  • To delineate the effect of uremia on any interaction between GH and protein intake, tests were performed before dialysis, after daily dialyses for 3-4 days and after withholding dialysis for 3-4 days [2].
  • Secretion of growth hormone after L-dopa stimulation in patients with renal failure treated with dialyses [3].
  • The possible benefits of LMW heparin (reduced frequency of bleeding, alleviation of hypertriglyceridemia) were not, however, apparent, possibly because of the short observation period and the low incidence of hemorrhagic complications in routine dialyses [4].
  • The 4-year experience in the clinical usage of titanium nails in making internal fistula for hemodialysis in 428 cases (17,829 dialyses) is reported [5].
 

High impact information on Dialysis

  • During 29 dialyses in 29 patients from three centers, the paired analysis of urea removed, as estimated by the dialysate monitor compared with the total dialysate collection, showed no significant difference (14.7 +/- 4.7 g versus 14.8 +/- 5.1 g) [6].
  • After changes in the preparation and use of heparin were instituted on December 4, 1978, no pyrogenic reactions occurred in more than 400 subsequent dialyses [7].
  • Double equilibrium dialyses demonstrated that 18-OH-B, aldo, and cortisol compete for binding sites on transcortin [8].
  • METHODS: During three to four baseline dialyses in each of 39 patients enrolled in the pilot phase of the HEMO Study, "A" was measured using an instrument that sampled dialysate frequently (Biostat), and V was calculated from A, C0, and Ceq (median CV for V = 5.6%) [9].
  • The initial dialysis (HD1) was performed with a low flux polysulfone dialyzer, the following dialyses (up to HD6) with a high flux polysulfone dialyzer and regular heparin [10].
 

Biological context of Dialysis

 

Anatomical context of Dialysis

 

Associations of Dialysis with chemical compounds

  • Eight men undergoing maintenance hemodialysis were each studied during two dialyses using glucose-free dialysate [15].
  • In a cross-over study with random assignment order eight adults underwent mid-week dialyses with ACD (0.113 mol/L citrate) and TSC (1.6 mol/L citrate) regional citrate anticoagulation [16].
  • C3a concentrations (microgram/mL) in the arterial and venous blood lines were significantly higher during cuprophan dialysis compared with hemophan and polyamide dialyses (P < 0.001) [17].
  • Comparison of victims' symptoms and pathology using animal studies of these two cyanotoxins leads us to conclude that the major contributing factor to death of the dialyses patients was intravenous exposure to microcystins, specifically microcystin-YR, -LR, and -AR [18].
  • With continued dialyses, without (2)H(2)O replacement, alanine from albumin enrichment gradually declined, whereas free alanine and water enrichments were negligible [19].
 

Gene context of Dialysis

  • Six patients had detectable pre-dialysis serum levels of IL1-B (greater than 20 pg/ml) at least once, and 2 had detectable levels prior to all dialyses [20].
  • Five patients had detectable pre-dialysis serum levels of TNF alpha (greater than 40 pg/ml) at least once and 2 had detectable levels prior to all dialyses [20].
  • The increase in concentration of ANP in plasma between dialyses, at a time when many patients are susceptible to sodium and water overload, and its return towards normal after dialysis supports the putative role of ANP as a circulating factor released in response to sodium and water accumulation [21].
  • Micro-organisms originating from the dialysate compartment invaded the blood compartment of ' Rhodial RP6 ' haemodialysers in 16 out of 639 dialyses investigated (2.5 per cent) [22].
  • The determination of the TAT complex concentration enabled a heparinization better adapted to the clinical situation of intensive-care patients undergoing acute dialyses, so that the coagulation system was not additionally activated by the extracorporeal circulation [23].
 

Analytical, diagnostic and therapeutic context of Dialysis

  • During control (1.5% dextrose) dialyses osmotic ultrafiltration was 0.28 mg/kg/min, the clearance of potassium was 0.98, urea 0.54, phosphate 0.32, and dextrose (reverse) 0.21 ml/kg/min [24].
  • Protein catabolic rate (PCR, in g protein/kg/day) for anuric patients can be accurately determined without blood sampling by equating urea generation over 7 days to the urea dialyzed in the three dialyses of this period as measured by partial dialysate collection (PDC) or with a urea monitor [25].
  • The investigation was made with 5 patients on long-term peritoneal dialysis once a week, first for 5 weeks with dialysis solution containing acetate and then, correspondingly, 5 dialyses with peritoneal solution containing lactate [26].

References

  1. Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis. Dunlay, R., Rodriguez, M., Felsenfeld, A.J., Llach, F. Kidney Int. (1989) [Pubmed]
  2. Effect of protein intake and dialysis on the abnormal growth hormone, glucose, and insulin homeostasis in uremia. Davidson, M.B., Fisher, M.B., Dabir-Vaziri, N., Schaffer, M. Metab. Clin. Exp. (1976) [Pubmed]
  3. Secretion of growth hormone after L-dopa stimulation in patients with renal failure treated with dialyses. Kuska, J., Kokot, F., Sledziński, Z. Acta medica Polona. (1979) [Pubmed]
  4. Low molecular weight heparin versus standard heparin. A long-term study in hemodialysis and hemofiltration patients. Schrader, J., Stibbe, W., Kandt, M., Warneke, G., Armstrong, V., Müller, H.J., Scheler, F. ASAIO transactions / American Society for Artificial Internal Organs. (1990) [Pubmed]
  5. Titanium nails used in A-V fistulation for hemodialysis in 428 patients. Wei, G., Sun, E.W., Lin, M.Z. Chin. Med. J. (1992) [Pubmed]
  6. Multicenter clinical validation of an on-line monitor of dialysis adequacy. Depner, T.A., Keshaviah, P.R., Ebben, J.P., Emerson, P.F., Collins, A.J., Jindal, K.K., Nissenson, A.R., Lazarus, J.M., Pu, K. J. Am. Soc. Nephrol. (1996) [Pubmed]
  7. Outbreak of pyrogenic reactions at a dialysis center. Association with infusion of heparinized saline solution. Kantor, R.J., Carson, L.A., Graham, D.R., Petersen, N.J., Favero, M.S. Am. J. Med. (1983) [Pubmed]
  8. Distribution of 18-hydroxycorticosterone between red blood cells and plasma. Zager, P.G., Frey, H.J., Spalding, C.T., Wengs, W.J., Brittenham, M.C. J. Clin. Endocrinol. Metab. (1986) [Pubmed]
  9. Imprecision of the hemodialysis dose when measured directly from urea removal. Hemodialysis Study Group. Depner, T.A., Greene, T., Gotch, F.A., Daugirdas, J.T., Keshaviah, P.R., Star, R.A. Kidney Int. (1999) [Pubmed]
  10. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients. Vanholder, R., Camez, A., Veys, N., Van Loo, A., Dhondt, A.M., Ringoir, S. Thromb. Haemost. (1997) [Pubmed]
  11. Acute renal failure during the Korean War. Teschan, P.E. Renal failure. (1992) [Pubmed]
  12. Effects of histamine and its receptor antagonists on peritoneal permeability. Shostak, A., Chakrabarti, E., Hirszel, P., Maher, J.F. Kidney Int. (1988) [Pubmed]
  13. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis. Vanholder, R.C., Ringoir, S.M. Blood Purif. (1990) [Pubmed]
  14. Complement C3 and C5 degradation products during hemodialysis treatment: study of an index of membrane bioincompatibility. Freyria, A.M., Leitienne, P., Veysseyre, C.N., Bringuier, J.P., Traeger, J. The International journal of artificial organs. (1988) [Pubmed]
  15. Amino acid losses during hemodialysis with infusion of amino acids and glucose. Wolfson, M., Jones, M.R., Kopple, J.D. Kidney Int. (1982) [Pubmed]
  16. Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A. Flanigan, M.J., Pillsbury, L., Sadewasser, G., Lim, V.S. Am. J. Kidney Dis. (1996) [Pubmed]
  17. On complement net generation in fast hemodialysis: are high blood flow rates bioincompatible? Skroeder, N.R., Kjellstrand, P., Holmquist, B., Kjellstrand, C.M., Jacobson, S.H. Am. J. Kidney Dis. (1995) [Pubmed]
  18. Human fatalities from cyanobacteria: chemical and biological evidence for cyanotoxins. Carmichael, W.W., Azevedo, S.M., An, J.S., Molica, R.J., Jochimsen, E.M., Lau, S., Rinehart, K.L., Shaw, G.R., Eaglesham, G.K. Environ. Health Perspect. (2001) [Pubmed]
  19. Quantifying rates of protein synthesis in humans by use of 2H2O: application to patients with end-stage renal disease. Previs, S.F., Fatica, R., Chandramouli, V., Alexander, J.C., Brunengraber, H., Landau, B.R. Am. J. Physiol. Endocrinol. Metab. (2004) [Pubmed]
  20. Tumor necrosis factor, interleukin-1 and beta 2-microglobulin levels in chronic hemodialysis patients. Caruana, R.J., Lobel, S.A., Leffell, M.S., Campbell, H., Cheek, P.L. The International journal of artificial organs. (1990) [Pubmed]
  21. Effect of haemodialysis on plasma concentrations of atrial natriuretic peptide in adult patients with chronic renal failure. Anderson, J.V., Raine, A.E., Proudler, A., Bloom, S.R. J. Endocrinol. (1986) [Pubmed]
  22. Bacterial contamination of the blood compartment originating from the dialysate in haemodialysers. Kolmos, H.J. J. Hosp. Infect. (1984) [Pubmed]
  23. The control of anti-coagulation in acute dialyses with sensitive laboratory parameters. Hafner, G., Swars, H., Ehrenthal, W., Schinzel, H., Weilemann, L.S., Prellwitz, W. Scand. J. Clin. Lab. Invest. (1992) [Pubmed]
  24. The mechanism of dextrose-enhanced peritoneal mass transport rates. Maher, J.F., Bennett, R.R., Hirszel, P., Chakrabarti, E. Kidney Int. (1985) [Pubmed]
  25. Protein catabolic rate determination from a single measurement of dialyzed urea. Garred, L.J., Canaud, B., Argiles, A., Flavier, J.L., Mion, C. ASAIO journal (American Society for Artificial Internal Organs : 1992) (1995) [Pubmed]
  26. A comparison between the effects of acetate and lactate in peritoneal dialysis solutions. Rossen, B., Ladefoged, J. Scandinavian journal of urology and nephrology. (1982) [Pubmed]
 
WikiGenes - Universities